Featured article: The Japanese Clinical Practice Guideline for acute kidney injury 2016
Acute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early detection and intervention are necessary to improve the outcomes of AKI patients.
Featured article: Low tongue pressure in peritoneal dialysis patients as a risk factor for malnutrition and sarcopenia: a cross-sectional study
Low tongue pressure contributes to oral frailty. It is a condition in which the pressure between the tongue, palate, and food decreases due to a decrease in tongue muscle function.
Featured article: Is hemodialysis itself a risk factor for dementia? An analysis of nationwide registry data of patients on maintenance hemodialysis in Japan
Chronic kidney disease is a major risk factor for dementia, but the influence of hemodialysis itself on the development of dementia remains unclear. We previously reported that non-diabetic patients on maintenance hemodialysis have preserved cognitive function; hemodialysis removes blood amyloid β (Aβ), which is a major cause of Alzheimer’s disease in the brain; and the number of Aβ deposits in the postmortem brains of hemodialysis patients was significantly less compared to that in age-matched controls not undergoing hemodialysis.
The 64th Annual Meeting of the Japanese Society for Dialysis Therapy
27 - 30 June 2019, Pacifico Yokohama
The 66th Annual Meeting of the Japanese Society for Dialysis Therapy
June 2021, Pacifico Yokohama
The 52nd Annual Meeting of the Japanese Society for Clinical Renal Transplantation
13-15 February 2019, Knowledge Capital Congress Convention Center
The 9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD)
5-7 September 2019, Nagoya Congress Center
The 25th Annual Meeting of the Japanese Society for Peritoneal Dialysis
23-24 November - 30 November 2019, Hiroshima International Conference Center
The 29th Annual Meeting of the Japan Society for Blood Purification Critical Care
19 - 20 October 2018, WINC Aichi
The 30th Annual Meeting of the Japan Society for Blood Purification Critical Care
26-27 October 2019, Hamamatsu ACT
The 9th Annual Meeting of the Japanese Society of Renal Rehabilitation
9-10 March 2019, B-ConPlaza (Beppu Convention Center)
Submit your manuscript
Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.
Aims and scope
Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.
RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.
Renal Replacement Therapy is the official publication of the following societies:
- Japanese Society for Dialysis Therapy (JSDT)
- Japanese Society for Clinical Renal Transplantation (JSCRT)
- Japanese Society for Peritoneal Dialysis (JSPD)
- Japan Society for Blood Purification in Critical Care (JSBPCC)
- Japanese Society of Renal Rehabilitation (JSRR)
Founded in 1968, the JSDT has over 16,000 members and is one of the largest societies in Japan. The JSDT promote advances in technology, research and the dissemination of knowledge related to renal replacement medicine. Japan remains a leader in renal replacement therapy including dialysis therapy, and the JSDT play a significant role in proposing clinical guidelines to improve the life prognosis and QOL of CKD patients.
The Japanese Society for Clinical Renal Transplantation (JSCRT) was founded in 1969 on the vision of promoting the advancement of the science and practice of renal transplantation. JSCRT has expanded to include nearly 1,500 renal transplant professionals, including surgeons, physicians, pediatrician, nurses, coordinators, social workers, pharmacists, and dieticians. JSCRT is also dedicated to educating renal transplant professionals, to promoting research, and to advocating the highest quality care for patients.
The Japanese Society for Peritoneal Dialysis (JSPD) aims to contribute to the advancement of medicine and medical practice, the development of academic culture and people’s welfare through implementing programs for advancement, development and propagation of medical practice and research regarding renal failure and peritoneal dialysis therapies for people all over Japan. JSPD was established in 1995, and has currently 1,500 members.
The Japan Society for Blood Purification in Critical Care was founded in 1990 and aims to further the development and establishment of acute blood purification, such as continuous renal replacement therapy (CRRT). JSBPCC comprises nephrologists, emergency/critical care physicians, as well as clinical engineers and nurses mainly working in intensive care units (ICU). JSBPCC is dedicated to the development of safe and effective blood purification therapy for saving the lives of critically ill patients.
The Japanese Society of Renal Rehabilitation (JERR) promotes the progress and disseminate of the knowledge of renal rehabilitation through the presentation of papers on theoretical studies of nephrology, comprehensive rehabilitation and its practical applications, exchange of knowledge, encouragement of continuing education for members, enhancement of mutual coordination and cooperation of members and also related domestic and foreign societies. JSRR was established in 2011, and has currently 640 members and 75 facilities.
About the Editor
Prof Takashi Shigematsu, Editor-in-Chief
Prof Shigematsu is currently Professor and Director of the Division of Nephrology, Department of Internal Medicine at the Wakayama Medical University School of Medicine, Japan. He is also Director of Blood purification Medicine, and Clinical Engineering at Wakayama Medical University Hospital, as well as a member of the International Society of Nephrology and the American Society of Nephrology.
His research interests focus on bone and mineral metabolism within chronic kidney disease (CKD). In addition, he has been investigating and working in fields of hemodialysis, peritoneal dialysis, blood purification medicine in acute kidney injury, kidney transplantation.
2017 Journal Metrics
34 days to first decision for reviewed manuscripts only
33 days to first decision for all manuscripts
134 days from submission to acceptance
21 days from acceptance to publication